Depletion of serotonin using p-chlorophenylalanine (PCPA) and reserpine protects against the neurotoxic effects of p-chloroamphetamine (PCA) in the brain
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 103 (2) , 111-115
- https://doi.org/10.1016/0014-4886(89)90071-x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Endogenously produced 5,6-dihydroxytryptamine may mediate the neurotoxic effects of para-chloroamphetamineBrain Research, 1987
- Serotonin in body fluids: Characterization of human plasmatic and cerebrospinal fluid pools by means of a new HPLC methodLife Sciences, 1985
- Prolongation of rat tail bleeding time by ketanserin: Mechanisms of actionEuropean Journal of Pharmacology, 1984
- STRUCTURE‐ACTIVITY RELATIONSHIPS AMONG THE HALOGENATED AMPHETAMINESAnnals of the New York Academy of Sciences, 1978
- Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamineEuropean Journal of Pharmacology, 1975
- Effect of some anorectic agents on the uptake and release of 5-hydroxytryptamine by blood platelets of ratsJournal of Pharmacy and Pharmacology, 1975
- Effect of p-chloroamphetamine on cerebral tryptophan-5-hydroxylase in vivo: A reexaminationNeuropharmacology, 1975
- Comparison of the oxime and the hydroxylamine derivatives of 4-chloroamphetamine as depletors of brain 5-hydroxyindolesBiochemical Pharmacology, 1974
- Serotonin oxidation by rat brain monoamine oxidase: Inhibition by 4-chloroamphetamineLife Sciences, 1966
- Site of Action of ReserpineActa Pharmacologica et Toxicologica, 1965